Aligos Therapeutics (5WK0) Ownership - Who Owns Aligos Therapeutics?
Aligos Therapeutics (5WK0) Ownership Overview
- 46.67% Insiders
- 4.22% Mutual Funds
- 31.17% Other Institutional Investors
- 3.36% ETFs
- 14.58% Public Companies and Individual Investors
The ownership structure of Aligos Therapeutics (DE:5WK0) stock is a mix of institutional, retail, and individual investors. Approximately 38.75% of the company’s stock is owned by Institutional Investors, 46.67% is owned by Insiders, and 14.58% is owned by Public Companies and Individual Investors.
The ownership structure of Aligos Therapeutics (DE:5WK0) stock is a mix of institutional, retail, and individual investors. Approximately 38.75% of the company’s stock is owned by Institutional Investors, 46.67% is owned by Insiders, and 14.58% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Woodline Partners Lp | €2,695,055 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Lawrence Blatt | 2,120,633 | Insider | 38.95% | 10,043,318 |
| Julian A. Symons | 394,064 | Insider | 7.24% | 1,866,287 |
| James Paul Scopa | 183,083 | Insider | 3.36% | 867,081 |
| Michael Rockefeller | 177,362 | Institution | 3.26% | 839,986 |
| Vanguard | 175,543 | Institution | 3.22% | 831,372 |
| Vanguard Index Funds | 175,543 | Institution | 3.22% | 831,372 |
| Felix Baker | 83,055 | Institution | 1.53% | 393,348 |
| Fidelity Concord Street Trust | 40,496 | Institution | 0.74% | 191,789 |
| BlackRock, Inc. | 30,292 | Institution | 0.56% | 143,463 |
| Ishares | 14,916 | Institution | 0.27% | 70,642 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 175,543 | Institution | 3.22% | 831,372 |
| Fidelity Concord Street Trust | 40,496 | Institution | 0.74% | 191,789 |
| Dfa Investment Dimensions Group Inc | 13,995 | Institution | 0.26% | 66,280 |
| Victory Portfolios Iii | 3,248 | Institution | 0.06% | 15,383 |
| John Hancock Variable Insurance Trust | 178 | Institution | <0.01% | 843 |
FAQ
Who Owns Aligos Therapeutics (DE:5WK0)?
According to the latest TipRanks data, approximately 38.75% of the company's stock is held by institutional investors, 46.67% is held by insiders, and 14.58% is held by public companies and individual investors.
What percentage of Aligos Therapeutics (DE:5WK0) stock is held by institutional investors?
According to the latest TipRanks data, approximately 38.75% of Aligos Therapeutics (DE:5WK0) stock is held by institutional investors: 4.22% by mutual funds, 3.36% by ETFs and 31.17% by other institutional investors.
What percentage of Aligos Therapeutics (DE:5WK0) stock is held by retail investors?
According to the latest TipRanks data, approximately 14.58% of Aligos Therapeutics (DE:5WK0) stock is held by public companies and individual investors.
Who owns the most shares of Aligos Therapeutics (DE:5WK0)?
LAWRENCE BLATT owns the most shares of Aligos Therapeutics (DE:5WK0).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
